Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. May 21, 2014; 20(19): 5660-5665
Published online May 21, 2014. doi: 10.3748/wjg.v20.i19.5660
Published online May 21, 2014. doi: 10.3748/wjg.v20.i19.5660
Helicobacter pylori eradication for preventing gastric cancer
Bin Lu, Meng Li, Department of Gastroenterology, the First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310006, Zhejiang Province, China
Author contributions: Lu B ideated and edited the manuscript; Lu B and Li M performed the review of the literature; Li M provided the primary draft of the manuscript; all authors read and approved the final version to be published.
Correspondence to: Bin Lu, MD, Department of Gastroenterology, the First Affiliated Hospital of Zhejiang Chinese Medical University, 54 Youdian Road, Hangzhou 310006, Zhejiang Province, China. lvbin@medmail.com.cn
Telephone: +86-571-8703-2028 Fax: +86-571-8707-7785
Received: October 3, 2013
Revised: November 15, 2013
Accepted: January 3, 2014
Published online: May 21, 2014
Processing time: 226 Days and 20.1 Hours
Revised: November 15, 2013
Accepted: January 3, 2014
Published online: May 21, 2014
Processing time: 226 Days and 20.1 Hours
Core Tip
Core tip: The treatment of gastric cancer (GC) is challenging. Elimination of a major risk factor, Helicobacter pylori (H. pylori) infection, represents an important approach for the prevention of GC. However, the feasibility and appropriate timing of this strategy remain to be determined. This review highlights the most recent literature and presents a comprehensive evaluation of what is currently known about H. pylori infections and GC.